Project Description

Active Ingredient: Melphalan hydrochloride 50mg

Dosage Form: Powder for solution for injection

Indication: It is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

Packaging: Box of 1 Powder  + 10mL vial of sterilised diluent

Manufacturer: GlaxoSmithKline – Italy

MAH: Aspen Pharma Trading Limited – Ireland